Clearview Cancer Institute achieves high concordance with NCCN Guidelines using Flatiron Assist
Clearview Cancer Institute, a multi-site cancer center in northern Alabama with 20 medical oncologists, adopted Flatiron Assist in March 2021 to embed current NCCN Clinical Practice Guidelines directly into the EHR workflow at the point of care. Since implementation, the practice achieved 95% concordance with NCCN Guidelines, reduced chart audit time by 20 hours per week, decreased prior-authorization processing time, and gained real-time clinical data analytics for quality tracking and utilization management.
Flatiron Health is a Roche-owned company supplying EHR-derived oncology real-world data, captured at the source through its own OncoEMR software.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Flatiron Health on its own site — read the original case study on resources.flatiron.com ↗
Related use cases
- 01Novartis - Taf + Mek external control analysis (BRAF V600E NSCLC), from Flatiron Health's RWE case studies (ResearchX Episode 5)
- 02Amgen - Lumakras/KRAS G12C natural history study, from Flatiron Health's RWE case studies (ResearchX Episode 5)
- 03Takeda - mobocertinib/Exkivity benchmark analysis, from Flatiron Health's RWE case studies (ResearchX Episode 5)
- 04A retrospective electronic health record-derived study supporting the accelerated approval of a new drug for mantle cell lymphoma in the U.S.
- 05Real-world clinical outcomes and comparative effectiveness of a drug in patients with recurrent ovarian cancer in the U.S.
- 06Kadcyla (T-DM1) in HER2+ mBC: Label Update on LVEF following a post approval commitment - based on RWD